Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tekla Life Sciences Investors

12.78
+0.03000.24%
Post-market: 12.780.00000.00%16:04 EDT
Volume:42.77K
Turnover:547.43K
Market Cap:368.99M
PE:-30.26
High:12.87
Open:12.78
Low:12.71
Close:12.75
Loading ...
Jun 03, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Apr 29, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Apr 17, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 07, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jan 13, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Dec 29, 2023

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Sep 13, 2023

Major Issues Report

Form 8-K - Current report
Aug 23, 2023

Correspondence

Form CORRESP - Correspondence
Jan 21, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
May 08, 2020

Correspondence

CORRESP [Cover] - Correspondence
Feb 03, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jul 10, 2019

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jul 18, 2017

Correspondence

Jun 19, 2017

Correspondence

Apr 18, 2016

Correspondence

Apr 18, 2016

Correspondence

与美国证券交易委员会(SEC)的通信
Jul 21, 2014

Correspondence

Jul 21, 2014

Correspondence

与美国证券交易委员会(SEC)的通信
May 28, 2014

Correspondence

May 23, 2014

Correspondence